Integrating strategic functional consulting expertise to accelerate your drug development timeline
Speed is rarely achieved by pushing one function harder. [...]
Strengthening rare-disease pharmacovigilance with curated real-world data
By Lucy Fulford-Smith, Head of Pharmacovigilance & Medical Services [...]
Navigating the first regulatory milestone: how to prepare a successful clinical trial application
Submitting a clinical trial application (CTA) is a pivotal [...]
Employing advanced analytics and artificial intelligence in rare-disease pharmacovigilance
By Lucy Fulford-Smith, Head of Pharmacovigilance & Medical Services [...]
The limits of traditional pharmacovigilance in rare diseases
By Lucy Fulford-Smith, Head of Pharmacovigilance & Medical Services [...]
How to choose the right functional service provider operating model for scaling your drug development programme
For small to mid‑sized biotech and pharma companies, building [...]
How a functional service provider approach can support your clinical study
Small and mid-sized biotechs and pharma companies live and [...]
How to drive regulatory success with effective medical writing
Submitting a dossier to the EMA or MHRA is [...]
How to manage serious adverse events in early-phase clinical trials
Reporting serious adverse events (SAE) is integral to running [...]
Your essential checklist for an effective regulatory submission
Bringing a new drug to market is a complex, [...]